Description

▪ Introduction

Trenbex 200 by Novotex Pharma contains Trenbolone Enanthate, a long-acting synthetic anabolic-androgenic compound initially developed for veterinary applications. In controlled research environments, it is studied for its potent anabolic activity, extended half-life, and its effects on muscle mass retention, nitrogen balance, and erythropoiesis (red blood cell production).

Each unit includes 10 × 1 mL ampoules dosed at 200 mg/mL, produced under strict pharmaceutical-grade standards to ensure purity, consistency, and sterility—intended solely for laboratory and analytical use.

▪ Product Details (Bulleted)

• Active Ingredient: Trenbolone Enanthate

• Concentration: 200 mg/mL

• Form: Injectable oil-based solution (intramuscular)

• Container Type: 10 sterile glass ampoules (1 mL each)

• Intended Use: Laboratory and analytical use

▪ Pharmacokinetics

Trenbolone Enanthate features an extended half-life of approximately 5–7 days, enabling less frequent injections in research protocols. It binds strongly to androgen receptors and does not undergo aromatization to estrogen, making it suitable for studies on anabolic signaling, nutrient partitioning, and hormonal modulation in non-clinical environments.

▪ Usage Recommendations

• Historic Veterinary Context: Previously used in veterinary medicine

• Current Use: For laboratory and analytical research purposes only

• Typical Frequency: Weekly or bi-weekly intramuscular administration, as per protocol

• Administration Route: Intramuscular injection using aseptic technique

• Use Statement: Strictly for laboratory and analytical use only

▪ Disclaimer

This product is intended exclusively for laboratory, veterinary, and research use. It is not approved for human consumption or therapeutic application. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with underlying health conditions. Always adhere to institutional protocols, safety practices, and local regulatory guidelines.